OP524-Characterization of mesenchymal stem cell induced regulatory B cells (MSC-induced Breg)

Núria Pujol Furelos, Marcella Franquesa*, Sergio G. Garcia*, Noelia Sandoval Hellin, Marta Clos Sansalvador, Francesc E. Borràs, Miriam Moron Font

*Corresponding author for this work

Research output: Contribution to conferenceAbstractAcademic

Abstract

Several studies described association between increase of regulatory B cells (Breg) and tolerance in kidney transplanted patients. However, a lack of unique defining Breg markers limits their clinical potential. Breg induction by mesenchymal stem cells (MSC) has been proposed to induce and expand Breg in vitro for downstream applications, that will constitute an optimal in vitro system to improve characterization and applicability of Breg.
Original languageEnglish
Pages103
Number of pages1
Publication statusPublished - 27-Aug-2021
Externally publishedYes
Event20th Biennial European Society for Organ Transplantation (ESOT) Congress - Milan, Italy
Duration: 29-Aug-20211-Sept-2021

Conference

Conference20th Biennial European Society for Organ Transplantation (ESOT) Congress
Country/TerritoryItaly
CityMilan
Period29/08/202101/09/2021

Fingerprint

Dive into the research topics of 'OP524-Characterization of mesenchymal stem cell induced regulatory B cells (MSC-induced Breg)'. Together they form a unique fingerprint.

Cite this